Sherwin-Williams Past Earnings Performance
Past criteria checks 3/6
Sherwin-Williams has been growing earnings at an average annual rate of 9.1%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 6.5% per year. Sherwin-Williams's return on equity is 61.5%, and it has net margins of 11.1%.
Key information
9.1%
Earnings growth rate
11.0%
EPS growth rate
Chemicals Industry Growth | 12.4% |
Revenue growth rate | 6.5% |
Return on equity | 61.5% |
Net Margin | 11.1% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sherwin-Williams makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 23,054 | 2,558 | 7,375 | 0 |
30 Jun 24 | 23,008 | 2,513 | 7,237 | 0 |
31 Mar 24 | 22,977 | 2,417 | 7,151 | 0 |
31 Dec 23 | 23,052 | 2,389 | 7,044 | 0 |
30 Sep 23 | 23,030 | 2,419 | 6,834 | 0 |
30 Jun 23 | 22,961 | 2,343 | 6,693 | 0 |
31 Mar 23 | 22,593 | 2,127 | 6,537 | 0 |
31 Dec 22 | 22,149 | 2,020 | 6,336 | 0 |
30 Sep 22 | 21,681 | 1,938 | 6,137 | 0 |
30 Jun 22 | 20,780 | 1,755 | 5,896 | 0 |
31 Mar 22 | 20,287 | 1,826 | 5,737 | 0 |
31 Dec 21 | 19,945 | 1,864 | 5,886 | 0 |
30 Sep 21 | 19,671 | 1,967 | 5,609 | 0 |
30 Jun 21 | 19,647 | 2,171 | 5,647 | 0 |
31 Mar 21 | 18,871 | 2,118 | 5,501 | 0 |
31 Dec 20 | 18,362 | 2,030 | 5,483 | 0 |
30 Sep 20 | 17,987 | 1,872 | 5,359 | 0 |
30 Jun 20 | 17,733 | 1,743 | 5,298 | 0 |
31 Mar 20 | 18,007 | 1,618 | 5,339 | 0 |
31 Dec 19 | 17,901 | 1,541 | 5,315 | 0 |
30 Sep 19 | 17,851 | 1,394 | 5,235 | 0 |
30 Jun 19 | 17,714 | 1,171 | 5,157 | 0 |
31 Mar 19 | 17,610 | 1,104 | 5,128 | 0 |
31 Dec 18 | 17,535 | 1,109 | 5,055 | 0 |
30 Sep 18 | 17,450 | 1,861 | 4,976 | 0 |
30 Jun 18 | 17,225 | 1,823 | 5,032 | 0 |
31 Mar 18 | 16,187 | 1,780 | 4,857 | 0 |
31 Dec 17 | 14,984 | 1,770 | 4,782 | 0 |
30 Sep 17 | 13,787 | 1,119 | 4,489 | 0 |
30 Jun 17 | 12,559 | 1,190 | 4,200 | 0 |
31 Mar 17 | 12,043 | 1,207 | 4,110 | 0 |
31 Dec 16 | 11,856 | 1,133 | 4,075 | 0 |
30 Sep 16 | 11,678 | 1,128 | 4,038 | 0 |
30 Jun 16 | 11,550 | 1,115 | 3,995 | 0 |
31 Mar 16 | 11,463 | 1,087 | 3,956 | 0 |
31 Dec 15 | 11,339 | 1,054 | 3,886 | 0 |
30 Sep 15 | 11,304 | 988 | 3,767 | 0 |
30 Jun 15 | 11,302 | 938 | 3,762 | 0 |
31 Mar 15 | 11,213 | 877 | 3,728 | 0 |
31 Dec 14 | 11,130 | 866 | 3,823 | 0 |
30 Sep 14 | 11,017 | 844 | 3,800 | 0 |
30 Jun 14 | 10,714 | 781 | 3,701 | 0 |
31 Mar 14 | 10,385 | 747 | 3,573 | 0 |
31 Dec 13 | 10,186 | 748 | 3,468 | 0 |
Quality Earnings: SJ3 has high quality earnings.
Growing Profit Margin: SJ3's current net profit margins (11.1%) are higher than last year (10.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SJ3's earnings have grown by 9.1% per year over the past 5 years.
Accelerating Growth: SJ3's earnings growth over the past year (5.7%) is below its 5-year average (9.1% per year).
Earnings vs Industry: SJ3 earnings growth over the past year (5.7%) did not outperform the Chemicals industry 7.2%.
Return on Equity
High ROE: Whilst SJ3's Return on Equity (61.54%) is outstanding, this metric is skewed due to their high level of debt.